HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,175,000 | +62.7% | 50,000 | +28.2% | 0.80% | +44.0% |
Q3 2019 | $722,000 | -0.4% | 39,000 | 0.0% | 0.55% | +11.0% |
Q2 2019 | $725,000 | -23.9% | 39,000 | 0.0% | 0.50% | -26.8% |
Q1 2019 | $953,000 | -5.8% | 39,000 | 0.0% | 0.68% | -24.2% |
Q4 2018 | $1,012,000 | -18.0% | 39,000 | 0.0% | 0.90% | +11.5% |
Q3 2018 | $1,234,000 | -18.5% | 39,000 | 0.0% | 0.81% | -24.8% |
Q2 2018 | $1,515,000 | – | 39,000 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |